南方制药 (831207.OC)

+ 收藏

利润表(南方制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 78,423,044.23165,369,870.0075,280,652.89160,249,897.9576,282,807.53
 营业收入(元) 78,423,044.23165,369,870.0075,280,652.89160,249,897.9576,282,807.53
二、营业总成本(元) 77,207,309.97165,780,155.3073,298,354.44152,373,828.0972,820,264.10
 营业成本(元) 51,719,290.91113,670,261.2149,422,607.53104,236,142.7050,682,384.69
 研发费用(元) 8,566,742.1412,983,590.889,032,846.1615,159,005.798,309,169.72
 营业税金及附加(元) 1,067,047.332,081,748.121,066,572.481,443,401.58604,867.17
 销售费用(元) 2,789,199.806,390,959.341,860,829.105,242,958.322,143,781.82
 管理费用(元) 12,520,497.3428,819,039.6211,294,132.1625,669,983.5810,984,869.30
 财务费用(元) 544,532.451,834,556.13621,367.01622,336.1295,191.40
  其中:利息费用(元) 993,668.912,028,291.35785,484.161,505,140.89591,898.04
  其中:利息收入(元) 45,259.69151,178.9999,594.25413,021.78307,639.78
三、其他经营收益
 加:投资收益(元) -10,808.37575,630.42343,211.251,392,407.27667,845.63
  其中:对联营企业和合营企业的投资收益(元) --327,415.81-160,817.94-
 资产处置收益(元) ---106,846.16-
 资产减值损失(元) --2,532,397.57-67,815.43-132,911.50-
 信用减值损失(元) -51,437.03-1,885,041.52-189,458.66-1,058,194.43-676,970.45
 其他收益(元) 4,969,792.417,735,341.353,952,381.895,781,108.503,538,021.41
四、营业利润(元) 6,123,281.273,483,247.386,020,617.5013,965,325.866,991,440.02
 加:营业外收入(元) 12,700.2439,775.3412,732.3213,458.614,501.28
 减:营业外支出(元) 2,691.96118,765.77-1,086,534.3684,633.26
五、利润总额(元) 6,133,289.553,404,256.956,033,349.8212,892,250.116,911,308.04
 减:所得税费用(元) 330,274.39782,068.82236,970.92432,402.12837,446.87
六、净利润(元) 5,803,015.162,622,188.135,796,378.9012,459,847.996,073,861.17
(一)按经营持续性分类
  持续经营净利润(元) 5,803,015.162,622,188.135,796,378.9012,459,847.996,073,861.17
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 6,016,478.732,729,334.515,786,597.4712,085,347.875,572,191.03
  少数股东损益(元) -213,463.57-107,146.389,781.42374,500.12501,670.14
 扣除非经常性损益后的净利润(元) 1,701,824.18-4,574,997.252,012,640.116,684,518.852,632,985.01
七、每股收益
 一、基本每股收益(元) 0.030.010.030.070.04
 二、稀释每股收益(元) 0.030.010.030.070.04
九、综合收益总额(元) 5,803,015.162,622,188.135,796,378.9012,459,847.996,073,861.17
 归属于母公司所有者的综合收益总额(元) 6,016,478.732,729,334.515,786,597.4712,085,347.875,572,191.03
 归属于少数股东的综合收益总额(元) -213,463.57-107,146.389,781.42374,500.12501,670.14
公告日期 2024-08-292024-04-232023-08-302023-03-312022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院